The development of a fluorescent multiplexed microarray platform able to detect and quantify a wide variety of pollutants in seawater is reported. The microarray platform has been manufactured by spotting 6 different bioconjugate competitors and it uses a cocktail of 6 monoclonal or polyclonal antibodies raised against important families of chemical pollutants such as triazine biocide (i.e. Irgarol 1051®), sulfonamide and chloramphenicol antibiotics, polybrominated diphenyl ether flame-retardant (PBDE, i.e. BDE-47), hormone (17βestradiol), and algae toxin (domoic acid). These contaminants were selected as model analytes, however, the platform developed has the potential to detect a broader group of compounds based on the cross-reactivity of the immunoreagents used. The microarray chip is able to simultaneously determine these families of contaminants directly in seawater samples reaching limits of detection close to the levels found in contaminated areas (Irgarol 1051®, 0.19 ± 0,06 µg L -1 ; sulfapyridine, 0.17 ± 0.07 µg L -1 ; chloramphenicol, 0.11 ± 0.03 µg L -1 ; BDE-47, 2.71 ± 1.13 µg L -1 ; 17β-estradiol, 0.94 ± 0.30 µg L -1 and domoic acid, 1.71 ± 0.30 µg L -1 ). Performance of the multiplexed microarray chip was assessed by measuring 38 blind spiked seawater samples containing either one of these contaminants or mixtures of them. The accuracy found was very good and the coefficient of variation was < 20% in all the cases. No sample pre-treatment was necessary, and the results could be obtained in just 1h 30 min. The microarray shows high sample throughput capabilities, being able to measure simultaneously more than 68 samples and screen them for a significant number of chemical contaminants of interest in environmental screening programs.
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INTRODUCTION
Over the last decades, marine pollution has been recognized as a worldwide problem and the state of the oceans has become a great concern to governmental agencies [1, 2] . Chemical contamination of estuarine and coastal areas, not only affects the biodiversity of the ecosystems, but also the oceans capacity to provide natural resources raising human health risks through the food chain [3, 4] . Main concerns for certain pollutants derive from the amounts generated by humans, their extremely negative effects on the environment or because of their accumulation in water, sediments, or biota. Included are endocrine disruptor chemicals (EDCs), a group of substances that may interfere with the endocrine and hormonal system of fishes and other non-vertebrate's organisms [5] [6] [7] . Some antibiotics, massively used in aquaculture facilities to combat fish infections and infestations, affect not only the ecosystem equilibrium but also human health spreading drug-resistant bacterial strains [8] .
Other groups of chemicals, such as persistent organic pollutants (POPs), are of concern due to their persistence, bioconcentration and biomagnification effects [9] . Finally, a growing concern about the relation between pollution, and toxic algal communities has arisen.
Recently, there has been a global increase of harmful algal blooms associated to elevated levels of marine biotoxins [10] . Those toxic compounds cause ecological and economic issues due to their effects on coastal marine resources and aquaculture facilities. The possibility of serious problems has resulted in the European legislation on regulations such as the Marine Strategy Framework Directive (MSFD), which focuses on the need to evaluate the negative effects of contaminants in aquatic organisms and the marine environment [11] .
Within this frame, the European Commission establishes environmental quality standards (EQS) to limit the concentrations of certain chemical substances that pose a significant risk to the environment or to human health in surface waters in the European Union (EU).
With this scenario, it is imperative to develop new approaches aimed to provide an accurate picture of the marine environmental health status in real time. Within this context, on July of 2012 the EC launched a call (FP7-OCEAN-2013) for proposals aimed at developing innovative real-time, in situ biosensors for monitoring the environmental status of marine water quality and provision of early-warning systems, in order to ensure sustainable management and exploitation of the seas and their resources. The technologies developed had to offer unique features for highly specific and precise measurements, including under multistressor conditions, by combining technological elements (including nanotechnologies) and bio-receptors in a single measurement device and remotely provide information on the environmental status.
One of the challenges to accomplish the required aim was to be able to simultaneously detect and quantify different families of chemical contaminants with minimum or without any sample preparation, at very low concentration levels, on a device able to work autonomously in situ (ocean, aquaculture facilities, etc). In the last years a variety of multiresidue chromatographic methods, usually coupled to tandem mass spectrometry showing high specificity and sensitivity have been reported (LC-MS/MS or GC-MS/MS) [9, [12] [13] [14] [15] [16] [17] .
However, these analytical approaches can hardly be implemented to work autonomously in situ in the middle of the ocean. The mass spectrometry technologies require highly sophisticated equipment supervised by qualified personnel and often, complex sample treatment procedures, often specific for one type of pollutant. As an alternative, immunochemical techniques based on antigen/antibody interaction have demonstrated to offer high levels of specificity sometimes for a class of compounds and detectability with no need or very simple sample pretreatment. In addition to their recognized high sample throughput capabilities, their flexibility have allowed their implementation in a variety of formats and devices (i.e. biosensor) with exceptional multiplexed capabilities if combined with class specific antibodies [18] [19] [20] [21] . From enzymatic assays [20, 22] , fluorescent immunoassays [23, 24] to biosensors [25] [26] [27] , several approaches to develop multiplexed analysis for environmental pollutants have been described.
The aim of the work presented here has been to develop and assess performance of a multiplexed immunochemical platform to detect and quantify, directly in seawater, six relevant families of potential marine contaminants including herbicides, sulfonamides and chloramphenicol antibiotics, frame retardants, hormones and algae toxins. For this purpose, a fluorescent microarray chip has been manufactured and used to develop the multiplexed immunochemical assay. As it will be shown, in spite of the variety of chemicals determined simultaneously, the technology shows very good analytical properties for its future implementation on an in-situ biosensor platform for monitoring the contamination of the ocean waters.
MATERIALS AND METHODS

Chemicals and Biochemicals
Domoic acid was purchased from Sigma Chemical Co. as well as the estradiol hapten; βestradiol 6-(O-carboxymethyl)oxime (6E2). The preparation of the bioconjugate competitors and antibodies has been performed with the support of the U2 of the ICTS "NANBIOSIS", more specifically by the Custom Antibody Service (CAbS, CIBER-BBN, IQAC-CSIC). The immunoreagents for Irgarol 1051 (Irg) [28, 29] , sulfonamide (SA) [18, 30] chloramphenicol antibiotics have been developed previously by our group [29, 31] . The immunoreagents used for the chloramphenicol assay will be described elsewhere. For the case of BDE-47, the immunoreagents preparation has been described in Shelver et al. 2005 [32] . The monoclonal antibody for estradiol was purchased from Fitzgerald Industries International (North Acton, Massachusetts, USA) and the monoclonal antibody for domoic acid (DA) was generated according to Traynor et al. 2006 [33] . The preparation of the corresponding bioconjugate competitors 6E2 4 BSA and DA 5 Louis, MO, USA) and prepared at 40 mg/mL in Ultrapure water. 
2.2.Equipment and General Procedures.
2.3.Buffers.
Unless otherwise indicated, phosphate buffer saline (PBS) is 0.01 M phosphate buffer in a 0.8% saline solution at pH 7.5. PBST is PBS with 0.05% Tween 20. The printing buffer 
2.4.Bioconjugate competitors
The preparation of the bioconjugate competitors for Irgarol 1051 [29] , sulfonamides [18, 30] , and BDE-47 [32] have been reported, while that of the chloramphenicol will be described elsewhere. The preparation of the bioconjugates for estradiol (6E2 4 BSA) and DA (DA 5 BSA) was performed using the following procedures. Briefly, a solution of N, N'dicyclohexylcarbodiimide (DCC; 50 μmol) in anhydrous DMF (50 μL) was added to a solution of the hapten (100 µL) in the same solvent followed by a solution of Nhydroxysuccinimide (NHS, 25 μmols, 50 µL) also in DMF [34] . The mixture was stirred for approximately 3 hours at RT until a white precipitate appeared. The suspension was then centrifuged (10000 rpm for 10 min) and the supernatant (25 µL for 6E2 and 50 µL for DA 5 ) was added dropwise to a solution of bovine serum albumin (BSA, 10 mg, 1.8 mL borate buffer) and the mixtures kept under gently stirred for 4 hours at RT. The protein bioconjugates were purified by dialysis against 0.5 mM PBS (4×5 L) and ultrapure water (1×5 L) and finally stored frozen at -40 °C. Unless otherwise indicated, working aliquots were stored at 4 °C in 0.01 M PBS at 1 mg mL -1 .
2.5.Manufacture of the microarray chip
Plain glass slides were first cleaned by immersing them in piranha solution (H 2 SO 4 :H 2 O 2 , 70:30, v/v, 30 min), rinsed with Ultrapure water, activated with 10% NaOH (30min) and then rinsed again with ultrapure water. Once the slides were cleaned, they were dried with N 2 , and the chemical functionalization of the slides was achieved using undiluted 3glycidyloxypropyltrimethoxysilane (GPTMS) (300 µL/slide, 30 min). Afterwards the slides were washed with ethanol, dried and stored in the desiccator until use. Biofunctionalization was performed by spotting solutions of the bioconjugate competitors (in PrB, 0.5-1nl spot -1 ) under controlled temperature (20ºC) and humidity (65%) conditions and maintaining them for 1 hour inside the microarrayer chamber. The biofunctionalized slides could be stored at RT in a desiccator until use. Up to 24 microarray chips could be printed in a single slide.
Microarray chips for single analyte analysis had 5 spots, while for multiplexed analysis consisted on a matrix of 5 x 6 spots (6 analytes, 5 replicates) according the scheme shown in Figure S1a .
2.6.Fluorescent microarray
General considerations
The slides were placed on an ArrayIt® holder provided with a silicon gasket defining 8x3 wells on each slide. Before starting the assay, the slides were washed three times with PBST.
Standard solutions used to calibrate the microarray were prepared in aSW (7 concentration points plus zero: 0.064 to 1000 nM for Irgarol 1051®, chloramphenicol and 17-β estradiol; from 0.128 to 2000 nM for sulfapyridine; and 0.64 to 10000 nM for BDE-47 and domoic acid). All the calibration curves were prepared in DMSO, and diluted 1 to 200 with aSW prior the assay. For the multiplexed microarray assays, a cocktail solution of antibodies was prepared. Optimum concentrations of the bioconjugates spotted and antisera/antibodies dilutions (see Table 2 ) were chosen by performing two-dimensional titration assays (2Dassay) and selecting those conditions able to generate a signal around 10.000 -20.000 RFUs (Relative Fluorescence Units) at 70-80% of the saturation curve. For this purpose, the binding of serial dilutions of the antisera/antibodies (zero and 1/1000 to 1/64000, using 100 μL well -1 ) to different concentrations of the bioconjugates spotted (zero and 200 μg mL -1 to 0.025 μg mL -1 ) were analyzed. Unless otherwise indicated, the results of single-analyte microarray assays correspond to assay performed in one-day using at least 3 spot replicates of each concentration whereas for the multiplexed microarray the results given were usually performed in 3 microarray chips performed on, at least 3 different days and using five-spots replicates.
Fluorescent microarray assay
Solutions (50µL/well) of the standards or the samples were added to the wells followed by solutions of single antibody or the Ab cocktail (in PBT2x, 50µL/well). After 30 min of incubation at RT, the slides were washed 3 times with PBST, and a solution containing a mixture of anti-mouse and anti-rabbit IgGs-TRITC conjugates (1/250 in PBST, 100 µL/well) was added. After another incubation of 30 min at RT in the dark, the slides were washed (3 x PBST + 1 x ultrapure water), dried with N 2 and read with the microarray scanner as described above (see Figure S1b ).
RESULTS AND DISCUSSION
A variety of chemicals have been identified as potential marine pollutants. Activities in offshore aquaculture resources involve the use of some of these substances, others from various human activities can produce detrimental effects in the aquatic ecosystem, placing public health at risk. Chemical discharges and runoff can affect aquaculture facilities. Hence, different pesticides, veterinary drugs, industrial residues, hormones or toxins have shown to be able to produce a strong negative impact in the marine environment particularly if bioaccumulation and/or persistence are involved [35, 36] .
To assess the environmental health of the ocean waters, we have addressed the development of a multiplexed bioanalytical system able to simultaneously detect and quantify a wide variety of contaminants. Based on their relevance and impact we have selected distinct representatives of some of the most important families of pollutants including herbicides, antibiotics, flame-retardants, hormones and algae toxins (see Figure 1 and Table 1 for chemical structures and reported levels of contamination). A key challenge was to be able to determine all of them directly in seawater in a single run, independently from their chemical nature and physico-chemical properties (see Table 1 ). Because of the diversity of chemical structures, these chemicals show significant differences in their hydrophilic/hydrophobic nature. While the herbicide Irgarol (ACD/LogP, 3.27) or the antibiotic chloramphenicol (ACD/LogP, 1.02) are considered to be hydrophilic, the brominated flame retardant BDE-47 (ACD/LogP, 7.39) is highly hydrophobic showing opposite properties regarding its solubility in water or behavior in respect to the extraction procedures or analytical conditions (see Table 1 ).
Immunochemical analytical tools offer the possibility to analyze a wide variety of substances under similar conditions due to the high sensitivity and specificity dependent on the antibodies. In this work we have been used immunoreagents previously developed or commercially available for triazines (i.e. Irgarol 1051®) [28, 29, 37] , sulfonamide [18, 30] , chloramphenicol, PBDEs (i.e. BDE-47) [38] , and domoic acid [33] . Dependent on the class specificity shown by some of these immunoreagents (i.e >10 sulfonamide antibiotic congeners are recognized by the immunoreagents used in this work), a microarray platform able to detect a large number of chemical substances [33] can potentially be developed.
Single-analyte microarrays for seawater analyses
Prior to its implementation in the final multiplexed microarray platform each single-analyte microarray was developed and used to assess its performance in seawater. This is a matrix characterized by its particular mixture of salts which provided a pH of 8.1 ± 0.2 (N=20) and a conductivity of 49.6 ± 1.5 mS cm -1 (N=20), much higher than the conductivity of the PBS buffer used in most of the assay (10 mM PBS, 16.0±0.5 mS cm -1 ). The six fluorescent microarray assays demonstrated good analytical features (LODs in the ppb or sub-ppb level) with similar performance in buffer and seawater; although in some cases (sulfonamides and 17β-estradiol) it was necessary to slightly modify the concentration of the antibody to accomplish the same analytical features as in PBST (see Table 2 ).
A challenge of monitoring contamination of marine water is the low concentration of the pollutants. Half of the analytes detected in this work have no EQS value set in the actual legislation; however, the EQS established by the Marine legislation are far below the ones achieved in this work (see Table 1 ) and by most of the reference analytical techniques proposed, unless a sample treatment/preconcentration step is introduced [39] . It should be noticed that the detectability values achieved by the single-analyte microarrays are close to the reported environmental levels (see Table 1 ).
3.2.Fluorescent Multiplexed Microarray
The possibility of cooperative phenomena or shared reactivity (recognition of a bioconjugate competitor by more than one antibody) was assessed to ensure that the signal recorded on each spot is only due to the binding of the corresponding specific antibody. Although the chemical structures of the selected targets are very different, the use of the same bioconjugation procedure could have led to undesired common epitopes [40] (see Table S1 ).
With this purpose, experiments were carried out to test the binding of each antibody to the different bioconjugates spotted on the glass slides. As shown in Figure 2 , the antibodies only recognized their corresponding antigen, ensuring the absence of shared reactivity.
Ensuring the lack of cooperative phenomena recognizing the target analytes was accessed by Figure 3 shows the comparison of the standard curves of each analyte on each situation. Although there was observed slight differences in shape, the analytical features summarized in Table 3 show that most of the assays maintain the same parameters once have been multiplexed (and being analyzed with the antibody cocktail), demonstrating that the use of the antibody cocktail does not affect the detectability of the selected analytes and that those can be quantified individually in the multiplexed platform. Thus, Irgarol 1051®, sulfapyridine, chloramphenicol, BDE-47, 17β-estradiol and domoic acid can be detected in the multiplexed format at 0.190 ± 0.06, 0.17 ± 0.07, 0.11 ± 0.03, 2.71 ± 1.13, 0.94 ± 0.30 and 1.71 ± 0.30 µg L -1 (N=3), respectively, also close to the reported environmental levels for these pollutants (see Table 1 ).
3.3.Accuracy of the multiplexed microarray
The objective of these experiments was to assess accuracy and to prove that the presence of more than one contaminant in the sample did not affect the quantification. For this purpose, 30 blind spiked samples were prepared in seawater containing the selected analytes at different concentrations, including zero and 5 different concentrations for each analyte. All the samples were analyzed during three different days using five-spot replicates of the multiplexed microarray chips. As it can be observed in Figure 4 , the linear regression studies provided slopes near 1 in all cases (being m=1.00 the perfect correlation) with very good regression coefficients (R 2 >0.95), indicating the excellent assay accuracy. The coefficients of variation (Table S2 ) were below of the 20% pointing to a good microarray assay precision.
Finally, blank seawater samples and spiked with mixtures of analytes were also quantified, to demonstrate the reliability of the platform. Table 4 summarizes the results obtained showing that when several analytes were present it was possible to obtain good levels of accuracy and precision. The coefficients of variation are almost in all cases below 20% and never greater than 25%. No false positives were observed since all the blank samples were negative for the six families of analytes.
CONCLUSIONS
A fluorescent microarray for the multiplexed determination and quantification of six different families of potential pollutants of the ocean has been developed and its suitability to analyze seawater samples has been evaluated. The microarray chips consisted on a matrix of 6x5 spots, which allow quantification of each pollutant using five-spot replicates. Seawater samples can be measured directly without any sample treatment in just about 1h 30 min, being possible to analyze simultaneously several samples using the necessary multi-well holder, which allows running 96 microarrays in parallel. Moreover, due to the wide selectivity of some of the immunoreagents used in this study is very much likely that the present microarray chip would be able to detect a significant number of chemical congeners The assays presented correspond to assays performed in one-day using at least 3 replicates of each concentration value, both in buffer and in seawater conditions. Microarray chips for single analyte analysis were contained 5 spots of the specific bioconjugate for each assay. -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  -B2  <LOD  -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  -B3  <LOD  -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  -B4  <LOD  -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  -B5  <LOD  -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  -B6  <LOD  -<LOD  -<LOD  -<LOD  -<LOD  -<LOD  - Two complex samples containing all the analytes at different concentrations (Irg:3nM;
Irgarol
SPy:10nM; CAP:4nM; BDE-47:40nM; E2:7nM and DA:30nM) were analyzed by the multiplexed platform. Each sample was detected using a cocktail antibody following the concentrations described in Table 2 , during three different days using at least 3 replicates for each concentration value. Microarray chips for multiplexed analysis were spotted in a matrix of 5
x 6 spots (6 analytes, 5 replicates).
